Filter by: Subject

Please note that UPSpace will be unavailable from Friday, 2 May at 18:00 (South African Time) until Sunday, 4 May at 20:00 due to scheduled system upgrades. We apologise for any inconvenience this may cause and appreciate your understanding.

Filter by: Subject

Results Per Page:

SDG-03: Good health and well-being (87)
South Africa (SA) (69)
Tuberculosis (TB) (67)
Human immunodeficiency virus (HIV) (59)
Mycobacterium tuberculosis (MTB) (36)
Multidrug-resistant (MDR) (24)
Sexually transmitted infection (STI) (24)
Antimicrobial resistance (AMR) (20)
Africa (16)
Pregnancy (15)
Drug resistance (14)
Escherichia coli (14)
Mycobacterium tuberculosis (13)
Bedaquiline (12)
Enterobacteriaceae (12)
Infection (12)
Multidrug-resistant tuberculosis (MDR-TB) (11)
Polymerase chain reaction (PCR) (11)
Whole genome sequencing (WGS) (11)
Women (11)
Antibiotic resistance (10)
Patients (10)
Pregnant women (10)
South Africa (10)
Antiretroviral therapy (ART) (9)
Colistin (9)
Ethiopia (9)
Klebsiella pneumoniae (9)
Molecular epidemiology (9)
Surveillance (9)
Epidemiology (8)
Sub-Saharan Africa (SSA) (8)
Treatment (8)
Whole-genome sequencing (WGS) (8)
Acinetobacter baumannii (7)
Carbapenemases (7)
Chlamydia trachomatis (7)
Clofazimine (7)
Coronavirus disease 2019 (COVID-19) (7)
COVID-19 pandemic (7)
Drug-resistant tuberculosis (DR-TB) (7)
Health sciences articles SDG-03 (7)
Neisseria gonorrhoeae (7)
Pulmonary tuberculosis (PTB) (7)
Antimicrobial resistance (6)
Bacteria (6)
Bacterial vaginosis (BV) (6)
Diagnosis (6)
Men who have sex with men (MSM) (6)
Pre-exposure prophylaxis (PrEP) (6)
Acquired immune deficiency syndrome (AIDS) (5)
Carbapenemase (5)
Colistin resistance (5)
Diagnostics (5)
Drug susceptibility testing (DST) (5)
Evidence for contraceptive options and HIV outcomes (ECHO) (5)
Extensively drug-resistant tuberculosis (XDR-TB) (5)
Gauteng Province, South Africa (5)
Microbiology (5)
Microbiome (5)
Population-based surveillance (5)
Pseudomonas aeruginosa (5)
Public health (5)
Risk factors (5)
Screening (5)
Staphylococcus aureus (5)
Transmission (5)
Vaccine (5)
Antibiotics (4)
Carbapenem (4)
Carbapenem resistance (4)
Children (4)
Clinical trials (4)
Clofazimine (CFZ) (4)
Genetic diversity (4)
Genotyping (4)
HIV infection (4)
HIV prevention (4)
Human (4)
Infants (4)
Infections (4)
Mobilome (4)
Mortality (4)
Multilocus sequence typing (MLST) (4)
Mutation (4)
Outbreak (4)
Prevalence (4)
Pulsed-field gel electrophoresis (PFGE) (4)
Resistome (4)
Rifampicin-resistant tuberculosis (4)
Rural South Africa (4)
Trichomonas vaginalis (4)
Urinary tract infection (UTI) (4)
Adolescent girls and young women (AGYW) (3)
Antenatal care (ANC) (3)
Anti-infective agents -- South Africa (3)
Biofilm (3)
Bovine mastitis (3)
Canada (3)
Ciprofloxacin (3)